MedPath

Effect of sivelestat, a neutrophil elastase inhibitor on cardiac surgical patients after cardiopulmonary bypass

Not Applicable
Conditions
cardiac and aortic disease
Registration Number
JPRN-UMIN000036507
Lead Sponsor
ippon Medical School
Brief Summary

In the control group, the levels of PMN elastase, IL-6, IL-8 in BAL showed a increase after CPB initiation, and were maintained at high levels 3 hours after CPB. In contrast, the sivelestat group had lower concentrations of PMN elastase, IL-6, IL-8 during and after CPB. The reduction in PaO2/FiO2 ratio after CPB was strongly related to the increase in IL-8, IL-6 or the elevation in PMN elastase.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

shock, pulmonary edema, liver dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
perioperative cytokine in bronchial bronchiolar lavage fluid, pulmonary function, oxygenation.
Secondary Outcome Measures
NameTimeMethod
myocardial injury, hemodynamics, perioperative cytokine in blood
© Copyright 2025. All Rights Reserved by MedPath